nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer
|
Ventimiglia, Eugenio |
|
|
2 |
3 |
p. 294-301 |
artikel |
2 |
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer
|
Lughezzani, Giovanni |
|
|
2 |
3 |
p. 329-332 |
artikel |
3 |
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies
|
van der Kwast, Theo H. |
|
|
2 |
3 |
p. 333-336 |
artikel |
4 |
Contents
|
|
|
|
2 |
3 |
p. iii-v |
artikel |
5 |
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations
|
Gandellini, Paolo |
|
|
2 |
3 |
p. 277-285 |
artikel |
6 |
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer
|
Akamatsu, Shusuke |
|
|
2 |
3 |
p. 320-328 |
artikel |
7 |
Editorial Board
|
|
|
|
2 |
3 |
p. i-ii |
artikel |
8 |
GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture
|
Jeyapala, Renu |
|
|
2 |
3 |
p. 231-238 |
artikel |
9 |
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
|
Williams, Stephen B. |
|
|
2 |
3 |
p. 265-273 |
artikel |
10 |
Management of Prostate Cancer Patients with Clinically Positive Lymph Nodes
|
Gillessen, Silke |
|
|
2 |
3 |
p. 302-303 |
artikel |
11 |
Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials
|
Bandini, Marco |
|
|
2 |
3 |
p. 248-256 |
artikel |
12 |
Mouse Models of Muscle-invasive Bladder Cancer: Key Considerations for Clinical Translation Based on Molecular Subtypes
|
Ruan, Jia-Ling |
|
|
2 |
3 |
p. 239-247 |
artikel |
13 |
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging
|
Truong, Matthew |
|
|
2 |
3 |
p. 257-264 |
artikel |
14 |
Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7–10 Prostate Cancer in Biopsy-naïve Men
|
Boesen, Lars |
|
|
2 |
3 |
p. 311-319 |
artikel |
15 |
Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417–27
|
Massari, Francesco |
|
|
2 |
3 |
p. 340-341 |
artikel |
16 |
Reply from Authors re: Peter Albers. Volume Matters: Can We Rely on the Evidence? Eur Urol Oncol 2019;2:274–5
|
Williams, Stephen B. |
|
|
2 |
3 |
p. 276 |
artikel |
17 |
Re: Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, et al. Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. Eur Urol Oncol 2019;2:320–328
|
Mazzone, Elio |
|
|
2 |
3 |
p. 338-339 |
artikel |
18 |
Re: Tom A. Hueting, Erik B. Cornel, Diederik M. Somford, et al. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Eur Urol Oncol 2018;1:411–7
|
Gandaglia, Giorgio |
|
|
2 |
3 |
p. 337 |
artikel |
19 |
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study
|
Weiner, Adam B. |
|
|
2 |
3 |
p. 304-310 |
artikel |
20 |
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign
|
Li, Roger |
|
|
2 |
3 |
p. 286-293 |
artikel |
21 |
Volume Matters: Can We Rely on the Evidence?
|
Albers, Peter |
|
|
2 |
3 |
p. 274-275 |
artikel |